Results 51 to 60 of about 31,692 (187)

Expression and Function of Eicosanoid-Producing Cytochrome P450 Enzymes in Solid Tumors

open access: yesFrontiers in Pharmacology, 2020
Oxylipins derived from the oxidation of polyunsaturated fatty acids (PUFAs) act as important paracrine and autocrine signaling molecules. A subclass of oxylipins, the eicosanoids, have a broad range of physiological outcomes in inflammation, the immune ...
Eric A. Evangelista   +3 more
doaj   +1 more source

Eicosanoids

open access: yes
This article describes the pathways of eicosanoid synthesis, eicosanoid receptors, the action of eicosanoids in different physiological systems, the roles of eicosanoids in selected diseases, and the major inhibitors of eicosanoid synthesis and action ...
Calder, Philip
core   +1 more source

Macronutrient and micronutrient profiles of meat types: insights into human health and diet

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Despite considerable advances in global health and nutrition, emerging challenges such as population growth, climate change, and limited natural resources continue to threaten food security. Meat remains an essential component of the human diet, supplying high‐quality proteins, essential amino acids, lipids, vitamins, and minerals necessary ...
Özgül Anitaş   +4 more
wiley   +1 more source

Eicosanoid Isolation from Mouse Intestinal Tissue for ELISA

open access: yesBio-Protocol, 2018
Activation of inflammasomes in peritoneal macrophages and intestinal epithelial cells (IEC) leads to the release of eicosanoids. To assess the amount of eicosanoids released by IEC, lipids need to be isolated from whole tissue previous to analysis by ...
Isabella Rauch
doaj   +1 more source

Bladder contributes to eicosanoids excreted in urine

open access: yes, 1990
The excretion of eicosanoids was examined in urine collected from the bladder or the ureter in normal rats. We found that the excretion of thromboxane B2 (the stable metabolite of thromboxane A2), prostaglandin E2, and 6-ketoprostaglandin F1 alpha was ...
S. Klahr, A. A. Reyes
core   +1 more source

Detection and Quantitation of Eicosanoids via High Performance Liquid Chromatography‐Electrospray Ionization‐Mass Spectrometry [PDF]

open access: yes, 2007
Eicosanoids constitute a large class of biologically active arachidonic acid (AA) metabolites that play important roles in numerous physiological processes.
Bowers‐Gentry, Rebecca   +9 more
core   +1 more source

Role of eicosanoids in liver repair, regeneration and cancer

open access: yes, 2021
Eicosanoids are lipid signaling molecules derived from the oxidation of ω-6 fatty acids, usually arachidonic acid. There are three major pathways, including the cyclooxygenase (COX), lipoxygenase (LOX), and P450 cytochrome epoxygenase (CYP) pathway ...
Alvarez, María de Luján   +1 more
core   +1 more source

Subcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives To summarise the demographic, clinical, histopathological, management and disease course of SPD.
Mason H. Crossman   +5 more
wiley   +1 more source

Eicosanoids and aneurysms

open access: yes, 2015
In the inflammatory process underlying aneurysm onset and progression, eicosanoidsseem to have an important role. Different hypotheses have been tested to describe thecourse of action.Interestingly, the imbalanced synthesis of cyclooxygenase-derived ...
RUVOLO, GIOVANNI   +3 more
core   +1 more source

Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases

open access: yesJournal of Lipid Research, 2003
Arachidonic acid inhibits adipocyte differentiation of 3T3-L1 cells via a prostaglandin synthesis-dependent pathway. Here we show that this inhibition requires the presence of a cAMP-elevating agent during the first two days of treatment.
Rasmus K. Petersen   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy